Immunologic changes point to potential for clinical investigation of combination immunotherapy for deadly kidney cancer
Immunologic changes observed in an early study of patients with metastatic renal cell carcinoma (MRCC) raised the possibility for a larger clinical study of combination immunotherapy, according to findings reported by researchers at The University of Texas MD Anderson Cancer Center.
The results of an open-label pilot study comparing combinations of anti-PD1 (nivolumab) alone, or in combination with either anti-CTLA-4 (ipilimumab...
Minority colorectal cancer patients report higher burden of poor quality-of-life than whites
A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that Hispanics...
Study provides path for new immunotherapy approaches to prostate cancer
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack...
Jerry Jeff Walker to headline April 29 Polo on the Prairie in West Texas
The 31st annual Polo on the Prairie, a U.S. Polo Association-sanctioned event benefiting cancer research and patient care programs at The University of Texas MD Anderson Cancer Center, is expected to attract nearly 1,000 polo enthusiasts, cancer fighters and fans of Texas country music legend Jerry Jeff Walker.
Gates open at 4 p.m. Saturday, April 29, at the Musselman Brothers’ Lazy 3 Ranch in Albany. The championship polo match...
MD Anderson expert to lead Dallas panels on Alzheimer’s disease
The University of Texas MD Anderson Cancer Center brings Jim Ray, Ph.D., head of Neuroscience, to Dallas on Thursday, April 20, to lead two...
Marshall E. Hicks named interim president of UT MD Anderson Cancer Center
University of Texas System Chancellor William H. McRaven announced today the appointment of Marshall E. Hicks, M.D., as interim president...
Advanced form of proton therapy shows promise for treating lung cancer recurrence
An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment...
Change in Leadership at MD Anderson
Ronald A. DePinho M.D., president of The University of Texas MD Anderson Cancer Center, has submitted a letter to Chancellor William H. McRaven...
Statement from The University of Texas System Chancellor William H. McRaven
When Dr. Ron DePinho was named president of The University of Texas MD Anderson Cancer Center by the Board of Regents in 2011, ...
Functional brain training alleviates chemotherapy-induced peripheral nerve damage in cancer survivors
A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy...
MD Anderson to provide skin cancer screenings, cancer prevention education at Shell Houston Open
Cancer prevention specialists from The University of Texas MD Anderson Cancer Center will provide skin cancer screenings free to the public...
Absent tumor-suppressors allow melanoma to thwart immunotherapy
It’s what’s missing in the tumor genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint...